Key RNAi Players Named in Witness Lists in Tuschl IP Dispute

The suit, filed by Alnylam and Max Planck against the University of Massachusetts, MIT, and the Whitehead Institute for Biomedical Research, is set to go to trial Feb. 22.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.